Literature DB >> 8423104

Analysis of the immune response in mice following intrauterine infection with the Chlamydia trachomatis mouse pneumonitis biovar.

S Pal1, T J Fielder, E M Peterson, L M de la Maza.   

Abstract

A Swiss Webster white mouse model of salpingitis was used to characterize the immune response following an intrauterine infection with the Chlamydia trachomatis mouse pneumonitis biovar. Western blot (immunoblot) analyses of the serum samples showed that the immunodominant bands corresponded to molecular masses of 72, 60, 42, and 28 kDa and to the lipopolysaccharide. Antibodies to the 60-kDa heat shock protein and to the 60-kDa cysteine-rich protein were detected at 2 and 3 weeks postinfection, respectively. Neutralization was observed in an in vitro assay with serum samples as early as the 3rd day postinfection and remained high for the 7 weeks of observation. The mice were mated in the 7th week following infection. Of the infected experimental mice, 71.4% were found to be either unilaterally or bilaterally infertile, whereas only 27.4% of the noninfected control mice were found to be infertile.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423104      PMCID: PMC302793          DOI: 10.1128/iai.61.2.772-776.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

Review 1.  Chlamydial salpingitis.

Authors:  L Weström; P A Mårdh
Journal:  Br Med Bull       Date:  1983-04       Impact factor: 4.291

2.  Infertility in mice infected genitally with a human strain of Chlamydia trachomatis.

Authors:  M Tuffrey; P Falder; J Gale; R Quinn; D Taylor-Robinson
Journal:  J Reprod Fertil       Date:  1986-09

3.  Infertility as a consequence of chlamydial infection of the upper genital tract in female mice.

Authors:  C E Swenson; J Schachter
Journal:  Sex Transm Dis       Date:  1984 Apr-Jun       Impact factor: 2.830

4.  Immune response in mice infected in the genital tract with mouse pneumonitis agent (Chlamydia trachomatis biovar).

Authors:  A L Barron; R G Rank; E B Moses
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

5.  Evidence of prior pelvic inflammatory disease and its relationship to Chlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women.

Authors:  D W Gump; M Gibson; T Ashikaga
Journal:  Am J Obstet Gynecol       Date:  1983-05-15       Impact factor: 8.661

6.  Host response to primary Chlamydia trachomatis infection of the fallopian tube in pig-tailed monkeys.

Authors:  D L Patton; S A Halbert; C C Kuo; S P Wang; K K Holmes
Journal:  Fertil Steril       Date:  1983-12       Impact factor: 7.329

7.  Chlamydia trachomatis-induced salpingitis in mice.

Authors:  C E Swenson; E Donegan; J Schachter
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

8.  A new animal model for the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis.

Authors:  A L Barron; H J White; R G Rank; B L Soloff; E B Moses
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

9.  Correlation between serum antichlamydial antibodies and tubal factor as a cause of infertility.

Authors:  R B Jones; B R Ardery; S L Hui; R E Cleary
Journal:  Fertil Steril       Date:  1982-11       Impact factor: 7.329

10.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  16 in total

1.  Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome.

Authors:  K H Ramsey; G S Miranpuri; I M Sigar; S Ouellette; G I Byrne
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo.

Authors:  R A Hawkins; R G Rank; K A Kelly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection.

Authors:  N Barteneva; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Characterization of the Horizontal and Vertical Sexual Transmission of Chlamydia Genital Infections in a New Mouse Model.

Authors:  Sukumar Pal; Delia F Tifrea; Luis M de la Maza
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

5.  Recognition of the 60 kilodalton cysteine-rich outer membrane protein OMP2 by CD4(+) T cells from humans infected with Chlamydia trachomatis.

Authors:  J C Goodall; H Beacock-Sharp; K H Deane; J S Gaston
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

6.  Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.

Authors:  S Pal; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Reactivation of chlamydial genital tract infection in mice.

Authors:  T W Cotter; G S Miranpuri; K H Ramsey; C E Poulsen; G I Byrne
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.

Authors:  L Bandholtz; M R Kreuger; C Svanholm; H Wigzell; M E Rottenberg
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

9.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

10.  Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility.

Authors:  L M de la Maza; S Pal; A Khamesipour; E M Peterson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.